1. The unattainable criteria for new infant vaccines.
- Author
-
Gill CJ, Hodsdon L, Santosham M, and O'Brien KL
- Subjects
- Cause of Death, Cost-Benefit Analysis, Female, Humans, Infant, Male, Meningococcal Infections immunology, Meningococcal Infections microbiology, Meningococcal Infections prevention & control, Meningococcal Vaccines economics, Neisseria meningitidis immunology, Treatment Outcome, United States epidemiology, Vaccination methods, Immunization Schedule, Infant Mortality, Meningococcal Infections mortality, Meningococcal Vaccines therapeutic use, Vaccination economics
- Abstract
Background: In 2013, the US Advisory Committee on Immunization Practices (ACIP) opted against adding meningococcal vaccines to the infant schedule due to poor cost-effectiveness. This raises a policy question: if meningococcal disease is too rare to justify routine vaccination, are there other vaccine-preventable causes of US infant deaths that could be supported?, Methods: We tabulated US infant deaths from 2009-2013 using the CDC WONDER database. These causes of death were then categorized into one of 3 categories: 1) vaccine-preventable using currently available interventions; 2) potentially vaccine-preventable within the next 10 years; and 3) not preventable., Results: From 19.8 million births (3.9 million/year), ∼122,000 infants died (0.62%). Of these, 181 (0.15% of all deaths) were preventable using currently available vaccines, while an additional 779 were categorized as potentially preventable in the next 10 y. By exclusion, 121,040 (99.2%) were judged 'not vaccine-preventable'. Meningococcal deaths contributed at most 0.03% of all infant deaths, but accounted for 17-34% of current vaccine-preventable deaths., Conclusions: The low number of vaccine-preventable deaths in the US makes it increasingly difficult to justify the introduction of any new infant vaccines.
- Published
- 2018
- Full Text
- View/download PDF